← Back to patent-cliff list
CAS 91-00-9
1,1-Diphenylmethylaminediphenylmethanamine
Codes: Tamsulosin Hydrochloride-078, AZEL-001
Application context (from source-drug indications)
Erectile dysfunctionTadalafil/TamsulosinBenign prostatic hyperplasiaTadalafil/TamsulosinLower urinary tract symptomsSolifenacin Succinate/Tamsulosin HydrochlorideBenign prostatic hyperplasiaSolifenacin Succinate/Tamsulosin HydrochlorideOveractive bladderSolifenacin Succinate/Tamsulosin HydrochlorideDrug-related adverse effects and reactionsSolifenacin Succinate/Tamsulosin HydrochlorideBladder neck obstructionSolifenacin Succinate/Tamsulosin HydrochlorideBenign prostatic hyperplasiaDutasteride/Tamsulosin HydrochlorideHypertensionOlmesartan Medoxomil/AzelnidipineBenign prostatic hyperplasiaTamsulosin HydrochlorideUrinary tract infectionTamsulosin HydrochlorideUrinary retentionTamsulosin HydrochlorideInguinal herniaTamsulosin HydrochlorideVoiding dysfunctionTamsulosin HydrochlorideLower urinary tract symptomsTamsulosin HydrochlorideHypertensionAzelnidipine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tadalafil/Tamsulosin | Tier C — Watch / trade | - |
| Solifenacin Succinate/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Dutasteride/Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Olmesartan Medoxomil/Azelnidipine | Tier C — Watch / trade | - |
| Tamsulosin Hydrochloride | Tier C — Watch / trade | - |
| Azelnidipine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(4-Methoxy-3-sulfamoylphenyl)acetic acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→1,1-Diphenylmethylamine→5-[(2R)-2-[(Diphenylmethyl)amino]propyl]-2-methoxybenzene-1-sulfonamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→1,1-Diphenylmethylamine→(2R)-N-(Diphenylmethyl)-1-(4-methoxyphenyl)propan-2-amine→(-)-2-(4-Methoxyphenyl)-1-methylethanamine→N-[(2R)-1-(4-Methoxyphenyl)propan-2-yl]acetamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine→3,5-Dimethylpyridine
(4-Methoxy-3-sulfamoylphenyl)acetic acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→1,1-Diphenylmethylamine→5-[(2R)-2-[(Diphenylmethyl)amino]propyl]-2-methoxybenzene-1-sulfonamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→1,1-Diphenylmethylamine→(2R)-N-(Diphenylmethyl)-1-(4-methoxyphenyl)propan-2-amine→(-)-2-(4-Methoxyphenyl)-1-methylethanamine→N-[(2R)-1-(4-Methoxyphenyl)propan-2-yl]acetamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine→3,5-Dimethylpyridine
(4-Methoxy-3-sulfamoylphenyl)acetic acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→1,1-Diphenylmethylamine→5-[(2R)-2-[(Diphenylmethyl)amino]propyl]-2-methoxybenzene-1-sulfonamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→1,1-Diphenylmethylamine→(2R)-N-(Diphenylmethyl)-1-(4-methoxyphenyl)propan-2-amine→(-)-2-(4-Methoxyphenyl)-1-methylethanamine→N-[(2R)-1-(4-Methoxyphenyl)propan-2-yl]acetamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine→3,5-Dimethylpyridine
diphenylmethanamine→2-(chloromethyl)oxirane→1-benzhydrylazetidin-3-ol→2-cyanoacetic acid→1-benzhydrylazetidin-3-yl 2-cyanoacetate→1-benzhydrylazetidin-3-yl 3-amino-3-iminopropanoate acetate→isopropyl (E)-2-(3-nitrobenzylidene)-3-oxobutanoate
(4-Methoxy-3-sulfamoylphenyl)acetic acid→2-Methoxy-5-(2-oxopropyl)benzene-1-sulfonamide→1,1-Diphenylmethylamine→5-[(2R)-2-[(Diphenylmethyl)amino]propyl]-2-methoxybenzene-1-sulfonamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine
(4-Methoxyphenyl)acetic acid→1-(4-Methoxyphenyl)-2-propanone→1,1-Diphenylmethylamine→(2R)-N-(Diphenylmethyl)-1-(4-methoxyphenyl)propan-2-amine→(-)-2-(4-Methoxyphenyl)-1-methylethanamine→N-[(2R)-1-(4-Methoxyphenyl)propan-2-yl]acetamide→(+)-2,2'-Dihydroxy-1,1'-dinaphthyl→(aR)-5,5',6,6',7,7',8,8'-Octahydro[1,1'-binaphthalene]-2,2'-diol→(aR)-4-Chloro-8,9,10,11,12,13,14,15-octahydro-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine→3,5-Dimethylpiperidine→3,5-Dimethylpyridine
diphenylmethanamine→2-(chloromethyl)oxirane→1-benzhydrylazetidin-3-ol→2-cyanoacetic acid→1-benzhydrylazetidin-3-yl 2-cyanoacetate→1-benzhydrylazetidin-3-yl 3-amino-3-iminopropanoate acetate→isopropyl (E)-2-(3-nitrobenzylidene)-3-oxobutanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.